As COVID-19 vaccine trials move ahead at a break-neck speed, an approved vaccine is likely to hit the Indian market by the first quarter of 2021, Bernstein said in a report. Globally, there are 4 candidates that are close to approval by the end of 2020 or early 2021. Through partnerships, India has access to two of those – AZ/Oxford's viral vector vaccine and Novavax's protein subunit vaccine.from IndiaTV India: Google News Feed https://ift.tt/2EMS17m
via
No comments:
Post a Comment
Please do not enter spam link in the comment box. Suggestions are invited for improvement.